Milagros C Cabrera, MD
Obstetrics/Gynecology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 34 years
- Rush Medical College of Rush University, 1992
Offices
1 location · UCSF Health Medical Foundation · 40 clinicians in this group
Hospitals listed: Ahmc Seton Medical Center · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cabrera’s office at (650) 756-2404 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$10,641
Medicare paid this office $10,641 for 75 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 24 | $2,578 | $68 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 45 | $2,132 | $47 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 13 | $738 | $57 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 16 | $283 | $18 |
Who their Medicare patients are
75 Original Medicare patients in 2024. Average age 72 · Women 100% · Also on Medicaid 24% · Health risk score 0.80. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 75% · Diabetes 41% · Coronary heart disease 17% · Chronic kidney disease 16% · Cancer 15%.
The office billed $39,809, Medicare allowed $13,697 and paid $10,641; for 327 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 75 | 327 | 72 | 0.80 | $39,809 | $10,641 |
| 2023 | 83 | 396 | 73 | 0.78 | $69,323 | $14,029 |
| 2022 | 68 | 426 | 72 | 0.82 | $36,138 | $10,002 |
| 2021 | 82 | 490 | 71 | 0.73 | $40,920 | $13,783 |
| 2020 | 78 | 331 | 72 | 1.18 | $40,688 | $12,015 |
| 2019 | 84 | 333 | 73 | 1.07 | $39,930 | $10,985 |
| 2018 | 79 | 331 | 71 | 1.09 | $33,056 | $13,540 |
| 2017 | 108 | 243 | 72 | 0.90 | $29,304 | $13,237 |
| 2016 | 97 | 212 | 72 | 1.08 | $28,225 | $14,055 |
| 2015 | 76 | 216 | 73 | 0.88 | $20,505 | $9,437 |
| 2014 | 108 | 371 | 72 | 0.99 | $38,060 | $18,484 |
| 2013 | 95 | 343 | 72 | 1.01 | $47,289 | $18,851 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 26 | $3,326 | $65 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 52 | $2,218 | $43 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 20 | $995 | $50 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 42 | $743 | $18 |
| Short return visit | 12 | $451 | $38 |
2022: 6 services
| Short return visit (20+ min) | 21 | $1,952 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 38 | $1,651 | $43 |
| New patient visit (15+ min) | 11 | $711 | $65 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 14 | $698 | $50 |
| Short return visit | 11 | $389 | $35 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 20 | $356 | $18 |
2021: 6 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 58 | $2,731 | $47 |
| Short return visit (20+ min) | 17 | $1,856 | $62 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 26 | $1,403 | $54 |
| Short return visit | 16 | $846 | $42 |
| New patient visit (15+ min) | 12 | $783 | $65 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 27 | $487 | $18 |
2020: 3 services
| Short return visit (20+ min) | 32 | $2,654 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,652 | $47 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 22 | $395 | $18 |
2019: 3 services
| Short return visit (20+ min) | 30 | $2,459 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 46 | $2,111 | $46 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 20 | $354 | $18 |
2018: 4 services
| Short return visit (20+ min) | 45 | $3,871 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 48 | $2,092 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 18 | $949 | $53 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 32 | $616 | $19 |
2017: 5 services
| Short return visit (20+ min) | 38 | $3,409 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 66 | $2,901 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 25 | $1,321 | $53 |
| New patient visit (30+ min) | 12 | $873 | $73 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 36 | $770 | $21 |
2016: 4 services
| Short return visit (20+ min) | 40 | $3,918 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 55 | $2,418 | $44 |
| New patient visit (30+ min) | 24 | $2,049 | $85 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 26 | $1,401 | $54 |
2015: 4 services
| Short return visit (20+ min) | 36 | $2,805 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 43 | $1,967 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 17 | $862 | $51 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 16 | $340 | $21 |
2014: 5 services
| Short return visit (20+ min) | 40 | $4,531 | $60 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 72 | $3,250 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 47 | $2,533 | $54 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 72 | $1,531 | $21 |
| New patient visit (30+ min) | 14 | $1,211 | $86 |
2013: 4 services
| Short return visit (20+ min) | 36 | $3,930 | $60 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 46 | $2,104 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 32 | $1,734 | $54 |
| New patient visit (30+ min) | 12 | $1,094 | $91 |
Medicaid work
$1,042 in 2018
Medicaid paid $1,042 for 40 billed services this clinician did in 2018, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 40 | $1,042 |
| 2018 | 40 | 1 | 15 | $1,042 |
Drugs they prescribed that Part D paid
$27,069
Pharmacies billed $27,069 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 131) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
107 generic and 24 brand-name prescriptions · $27,069 in drug cost · 13 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prolia | 12 | $20,827 | $1,736 |
| Estradiol | 13 | $579 | $45 |
| Alendronate | 19 | $165 | $9 |
| Triamcinolone Acetonide | 28 | $70 | $3 |
Year by year
| 2024 | 131 | 64 | 0% (0) | 18% | $27,069 |
| 2023 | 95 | 46 | 0% (0) | 18% | $13,713 |
| 2022 | 122 | 56 | 0% (0) | 16% | $15,637 |
| 2021 | 112 | 48 | None | 15% | $18,427 |
| 2020 | 125 | 61 | None | 18% | $13,075 |
| 2019 | 120 | 57 | 0% (0) | 28% | $15,647 |
| 2018 | 129 | 59 | None | 34% | $18,310 |
| 2017 | 149 | 63 | None | 38% | $32,772 |
| 2016 | 164 | 62 | 0% (0) | 38% | $20,369 |
| 2015 | 197 | 57 | None | 25% | $13,697 |
| 2014 | 210 | 62 | None | 24% | $12,902 |
| 2013 | 163 | 56 | None | 28% | $10,784 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Triamcinolone Acetonide | 17 | $65 | $4 |
2022: 3 drugs
| Premarin | 11 | $4,989 | $454 |
| Triamcinolone Acetonide | 24 | $114 | $5 |
| Alendronate | 15 | $78 | $5 |
2021: 3 drugs
| Estradiol | 11 | $1,499 | $136 |
| Triamcinolone Acetonide | 20 | $115 | $6 |
| Alendronate | 12 | $29 | $2 |
2020: 4 drugs
| Premarin | 12 | $5,230 | $436 |
| Estradiol | 11 | $1,213 | $110 |
| Amethyst | 13 | $416 | $32 |
| Triamcinolone Acetonide | 19 | $95 | $5 |
2019: 3 drugs
| Premarin | 22 | $7,476 | $340 |
| Alendronate | 16 | $171 | $11 |
| Triamcinolone Acetonide | 16 | $91 | $6 |
2018: 2 drugs
| Premarin | 26 | $6,898 | $265 |
| Oxybutynin Chloride Er | 12 | $610 | $51 |
2017: 3 drugs
| Premarin | 20 | $4,766 | $238 |
| Alendronate | 20 | $343 | $17 |
| Triamcinolone Acetonide | 13 | $104 | $8 |
2016: 4 drugs
| Premarin | 33 | $8,248 | $250 |
| Oxybutynin Chloride Er | 11 | $929 | $84 |
| Alendronate | 24 | $256 | $11 |
| Estradiol | 11 | $69 | $6 |
2015: 5 drugs
| Premarin | 32 | $6,437 | $201 |
| Oxybutynin Chloride Er | 11 | $618 | $56 |
| Alendronate | 41 | $221 | $5 |
| Triamcinolone Acetonide | 17 | $119 | $7 |
| Estradiol | 16 | $114 | $7 |
2014: 5 drugs
| Premarin | 36 | $6,477 | $180 |
| Alendronate | 49 | $593 | $12 |
| Oxybutynin Chloride Er | 11 | $367 | $33 |
| Triamcinolone Acetonide | 17 | $126 | $7 |
| Estradiol | 18 | $98 | $5 |
2013: 2 drugs
| Premarin | 29 | $4,138 | $143 |
| Alendronate | 34 | $446 | $13 |
Money from drug and device companies
$69 in 2025
| 2025 | 2 | 3 | None | $69 |
| 2024 | 9 | 11 | None | $331 |
| 2023 | 2 | 4 | None | $92 |
| 2022 | 3 | 3 | None | $73 |
| 2021 | 3 | 5 | None | $105 |
| 2020 | 6 | 10 | None | $258 |
| 2019 | 6 | 10 | None | $401 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Minerva Surgical | None | $41 | 2 payments
|
| Astellas Pharma US | Veozah | $29 | 1 payment
|
See all 3 published payments
| Minerva Surgical | Meals · 2025-04-07 | None | $21 |
| Minerva Surgical | Meals · 2025-04-07 | None | $20 |
| Astellas Pharma US | Meals · 2025-01-31 | Veozah | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $331
| Astellas Pharma US | Veozah | $104 | 2 payments
|
| Hologic Sales and Service | Aptima | $56 | 2 payments
|
| Ethicon US | Ethicon | $35 | 1 payment
|
| Biogen | None | $31 | 1 payment
|
| Amgen | Evenity | $28 | 1 payment
|
| Organon | Nexplanon | $26 | 1 payment
|
| Minerva Surgical | None | $20 | 1 payment
|
| CooperSurgical | Paragard T 380a | $16 | 1 payment
|
| Pfizer | Abrysvo | $16 | 1 payment
|
2023: $92
| AbbVie | Orilissa | $49 | 2 payments
|
| Astellas Pharma US | Veozah | $43 | 2 payments
|
2022: $73
| Hologic | Thinprep 2000 Processor | $29 | 1 payment
|
| Agile Therapeutics | Twirla | $22 | 1 payment
|
| Abbvie | Lo Loestrin Fe | $21 | 1 payment
|
2021: $105
| AbbVie | Lo Loestrin Fe | $80 | 3 payments
|
| Agile Therapeutics | Twirla | $13 | 1 payment
|
| Mylan Pharmaceuticals | Xulane | $12 | 1 payment
|
2020: $258
| Amgen | Evenity | $95 | 3 payments
|
| Hologic | Aptima Hpv | $65 | 3 payments
|
| Roche Diagnostics | Rs Harmony Test Related Products | $32 | 1 payment
|
| Exeltis USA | Nuvessa | $25 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $20 | 1 payment
|
| AbbVie | Lo Loestrin Fe | $20 | 1 payment
|
2019: $401
| Amgen | Evenity | $181 | 3 payments
|
| Axogen | Axoguard Nerve Connector | $107 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $38 | 2 payments
|
| Merck Sharp & Dohme | Nexplanon | $35 | 2 payments
|
| Hologic | Aptima Hpv | $24 | 1 payment
|
| Allergan | Lo Loestrin Fe | $15 | 1 payment
|
Professional record
- NPI
- 1316026099
- Licence
- CA G078372
- Trained
- Rush Medical College of Rush University, 1992 · 34 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA GR0041950
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1850 Sullivan Ave, Suite 312, Daly City, CA, 94015
- NPI first listed
- 2006-11-03
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.